Category: Covid-19

  • Covid Paper Retracted Over Industry Links

    Covid Paper Retracted Over Industry Links

    Photo: Soloviova Liudmyla

    The European Respiratory Journal has retracted a scientific paper claiming current smokers are 23 percent less likely to be diagnosed with Covid-19 compared to nonsmokers after it was discovered some of the paper’s authors had financial links to the tobacco industry, reports The Guardian.

    The World Health Organization has warned that because smoking impairs lung function, there is an increased risk of severe symptoms if respiratory infections, including coronaviruses, are acquired by smokers. Covid-19 is an infectious disease that primarily attacks the lungs.

    But the paper, published in July last year by the European Respiratory Journal, found “current smoking was not associated with adverse outcome” in patients admitted to hospital with Covid-19 and claimed smokers were at a significantly lower risk of acquiring the virus.

    The article was originally published “early view” on July 30, 2020. Subsequent to this, and prior to publication of the version of record in an issue of the European Respiratory Journal, it was brought to the editors’ attention that two of the authors had failed to disclose potential conflicts of interest at the time of the manuscript’s submission.

    I disagree with the retraction, and I consider it unfair and unsubstantiated.

    Jose M. Mier at the time provided consultancy services to the tobacco industry on tobacco harm reduction. Konstantinos Poulas at the time was a principal investigator for the Greek NGO NOSMOKE, a science and innovation hub that has received funding from the Foundation for a Smoke-Free World, which in turn has received funding from the tobacco industry.

    After careful review of the manuscript content alongside the new disclosures brought to light, the editors and society agreed that if these conflicts of interest had been disclosed at the time of manuscript submission, the editors would not have considered the article for publication.

    The European Respiratory Society has bylaws in place that do not permit individuals with ongoing relationships with the tobacco industry to participate in its activities.

    The editors of the European Respiratory Journal acknowledged that, aside from the failure of two contributing authors to disclose their conflicts of interest relating to the tobacco industry, at no point was there a question of any scientific misconduct on the part of any of the authors.

    The senior author of the paper, Konstantinos Farsalinos, said in a statement to the website Retraction Watch that the conflicts of interest “were irrelevant to the study’s main aims and objectives.”

    “Additionally, I proposed to publicly release the full dataset and the statistical script so that all findings could be independently verified,” he said. “The editors declined. I requested my proposal to be mentioned in the retraction letter, but that was also rejected by the editors. I disagree with the retraction, and I consider it unfair and unsubstantiated.”

  • KT&G Helps Farmers Affected by Covid-19

    KT&G Helps Farmers Affected by Covid-19

    Photo: KT&G

    KT&G provided a leaf tobacco planting service in Jecheon, Chungcheongbuk-do, to help leaf tobacco farmers struggling due to manpower shortages in the aftermath of the Covid-19 pandemic.

    Employees of KT&G’s Raw Materials Headquarters and Gimcheon Plant, who participated in the volunteer work, visited a leaf tobacco farm in Baegun-myeon, Jecheon-si, Chungcheongbuk-do, where they helped raise and plant seedlings in farmland of about 10,000 square meters.

    “In addition to the declining population and aging population in rural areas, labor shortages have worsened due to the Covid-19 pandemic, and farmers are experiencing great difficulties,” said Shin Sang-ho, head of KT&G’s raw materials division, in a statement.

    “KT&G has been working to alleviate the grievances of farmers by deploying leaf tobacco planting and harvesting volunteers every year and will continue to strive for win-win growth with farmers through various activities.”

    In addition to the declining population and aging population in rural areas, labor shortages have worsened due to the Covid-19 pandemic.

    KT&G is the only tobacco company operating in Korea to purchase domestic leaf tobacco and is making various efforts to protect farm households, such as prepaying 30 percent of the sales price of leaf tobacco for each farmer in cash. In addition, from 2013 to the present, the company has provided health checkups for farmers and scholarships for their children.

  • New Tobacco-Based Vaccine Candidate

    New Tobacco-Based Vaccine Candidate

    Photo: torstensimon from Pixabay

    Akdeniz University in Turkey has developed an anti-Covid-19 drug and vaccine candidate using a protein produced by the tobacco plant Nicotiana Benthamiana, reports Hurriyet Daily News.

    The product is based on an angiotensin-converting enzyme 2 (ACE2), an enzyme attached to the human body’s cell membranes in the lungs, arteries, heart, kidney and intestines. The Covid-19 virus blocks ACE2, which leads to significant health problems.  

    “With the transient plant expression system, we have achieved a high rate of production of this enzyme,” said Tarlan Mammedov, a member of the university’s faculty of agriculture and a member of the vaccine science board of the Biotechnology Institute of the Presidency of the Turkish Institutes of Health.

    The treatment can be applied as an injection and as a spray, according to Mammedov.

    Akdeniz University tested its vaccine candidates on mice with live viruses and found a high level of inhibition of the live virus from entering the cell.

    It is now seeking funding to conduct clinical trials with humans. Mammedov said the drug could be released within four months.

    Akdeniz University is not the first institution to use tobacco for vaccine development. Other tobacco-based Covid-19 vaccine candidates are being developed by British American Tobacco, Medicago and Chulalongkorn University in Bangkok.

  • Manila Drops Vaccine-Purchasing Ban

    Manila Drops Vaccine-Purchasing Ban

    Image: Malacanan Palace Presidential Museum & Library

    Tobacco companies in the Philippines will be allowed to purchase Covid-19 vaccines after all, reports The Manila Times, citing a statement from the presidential palace.

    The announcement follows controversy over proposed implemented rules and regulations of the Coronavirus Disease 2019 Vaccination Program Act of 2021, which would have barred manufacturers of tobacco, milk and sugary beverages from procuring vaccines for their workers.

    Those provisions have now been removed, according to The Manila Times.

    In 2010, the Civil Service Commission and the Department of Health (DOH) issued a joint memorandum banning all forms of government interaction with the tobacco industry.

    It is one thing to discourage smoking or lactose intolerance and quite another to destroy the livelihood and the lives of people who depend on the tobacco, milk, sugar and soda companies, which pay more taxes than the directors of PhilHealth have stolen.

    This memorandum was being cited by the DOH in moving to ban tobacco and select other industries from availing of Covid-19 vaccines from the government.

    “The DOH, in its review, shall ensure that the tobacco, formula milk and other industries in conflict with the interest of public health will not be part of this endeavor pursuant to existing DOH guidelines and issuances,” the draft regulations said.

    The move attracted widespread criticism. Foreign Affairs Secretary Teodoro Locsin likened it to the Nazi-era when leaders decided who would live or die. “It is one thing to discourage smoking or lactose intolerance and quite another to destroy the livelihood and the lives of people who depend on the tobacco, milk, sugar and soda companies, which pay more taxes than the directors of PhilHealth [Philippine Health Insurance Corp.] have stolen,” he said.

    Health Undersecretary Maria Rosario Vergeire stressed that the administrative order leaked online was a draft.

    She added that the Philippines is party to the World Health Organization’s Framework Convention on Tobacco Control that prevents tobacco-related industries from providing health-related services for marketing advocacy.

  • Video: Coping With Covid

    Video: Coping With Covid

    Watch Cara Leach, Patricia Kovacevic, Monica Vialpando and Elise Rasmussen discuss how the Covid-19 pandemic has affected them personally and professionally.

  • South Africa: Cigarette Ban ‘Successful’

    South Africa: Cigarette Ban ‘Successful’

    Photo: Heinrich Botha from Pixabay

    A recent study shows that South Africa’s cigarette ban in 2020 helped reduce the number of lung disease-related emergency room visits, reports Herald Live.

    South Africa banned tobacco sales from March to August 2020 to help prevent the spread of the coronavirus. In December, the country’s High Court ruled that the measure was unconstitutional. The government is appealing the judgment.

    Published in the African Journal of Primary Health Care & Family Medicine, the study showed that emergency center visits for chronic obstructive pulmonary disease (COPD) at the George Regional Hospital in the Western Cape fell by 69.28 percent between January and August 2020 compared with the same period in 2019.

    Whilst the tobacco sales ban has had detrimental effects on economy, one of the benefits has been a reduction in emergency center attendance of patients with COPD exacerbations compared with that during the same period from the previous year.

    “This notable reduction in COPD presentations reduced service pressure of emergency center and most likely benefited patients’ health,” the study states. “Whilst the tobacco sales ban has had detrimental effects on economy, one of the benefits has been a reduction in emergency center attendance of patients with COPD exacerbations compared with that during the same period from the previous year. Further research and policies are needed to ensure ongoing reduction in the prevalence of smoking.”

    According to the study, only 9 percent of smokers quit during the lockdown.

    An online survey of smokers found that 93 percent maintained their habit by paying up to 250 percent more for illicit products.

    South Africa, Botswana and India implemented smoking bans as part of their Covid-19 restrictions. India’s ban lasted six weeks, Botswana’s ban lasted 12 weeks and South Africa’s ban lasted five months.

  • More Tobacco Use During Lockdown

    More Tobacco Use During Lockdown

    Photo: Tobacco Reporter archive

    Pandemic-related anxiety, boredom and irregular routines were cited as major drivers of increased nicotine and tobacco use during the initial Covid-19 lockdown, according to research just released by Columbia University’s Mailman School of Public Health. The study highlights ways that public health interventions and policies can better support quit attempts and harm reduction, both during the Covid-19 pandemic and beyond. The findings are published in the International Journal of Drug Policy.

    Between April and May 2020, the researchers conducted telephone interviews with adults across the United States who use cigarettes and/or electronic nicotine-delivery systems (ENDS), such as e-cigarettes. Participants in the study were recruited using an advertisement campaign on Facebook and Instagram. During this window, nearly 90 percent of the U.S. population experienced some form of state lockdown, with 40 states ordering nonessential businesses to close and 32 states enacting mandatory stay-at-home orders. At the time of their interviews, all participants were voluntarily isolating at home unless required to leave the house.

    Nearly all participants reported increased stress related to Covid-19—namely, fears about the virus, job uncertainty and the psychological effects of isolation—and described this as the primary driver of increased nicotine and tobacco use. Decreased use, while less common, was prevalent among “social” tobacco users, who cited fewer interpersonal interactions during lockdown and a fear of sharing products.

    At the community level, retail access impacted cigarette and ENDS use differently. While cigarettes were universally accessible in essential businesses, such as convenience stores and gas stations, access to preferred ENDS products was more limited since vape shops and other specialty ENDS retailers were typically deemed nonessential and required to close or limit hours. This drove some ENDS users to order their products online, which often resulted in long wait times due to shipping delays or product backorder as a result of high demand. As a result, some dual users of cigarettes and ENDS increased their use of readily available cigarettes.

    “Pandemic response policies that intentionally or inadvertently restrict access to lower risk products—through availability, supply chains or even postal service slowdowns—while leaving more harmful products widely accessible may have unintended consequences that should be considered during policy development,” said Daniel Giovenco, assistant professor of sociomedical sciences at Columbia Mailman School and the study’s lead author.

    Given that tobacco use behaviors are expected to increase among some individuals during this sustained period of uneasiness, Giovenco and colleagues proposed several key policy recommendations: expansion of cessation resources and services, including their adaptation for remote delivery; establishment and enforcement of smoke-free home rules to protect household members; and enabling equivalent access to lower risk products—such as ENDS and nicotine-replacement therapy—to facilitate harm reduction among those who cannot or do not want to quit using nicotine at this time.

    “While quantitative, survey-based studies provide valuable insight into changes in tobacco use during lockdown periods, existing research has drawn mixed conclusions. Our approach was the first to qualitatively capture the complex drivers and mechanisms that may help explain varied behavioral shifts,” noted Giovenco. “Covid-19 mitigation strategies to curb transmission will likely continue for the foreseeable future, with many permanently altering elements of the workplace, education and consumer behaviors. Our findings can help tailor intervention and policy work to address multi-level determinants of tobacco use in the Covid[-19] era and the years ahead.”

  • Minister May Appeal Tobacco Ban Ruling

    Minister May Appeal Tobacco Ban Ruling

    Photo: Alexlmx | Dreamstime.com

    The Western Cape High Court has granted South African Minister Nkosazana Dlamini-Zuma permission to appeal the ruling that last year’s lockdown ban on tobacco sales was unconstitutional and invalid.

    However, the court indicated that the minister’s prospects of success are slim in terms of the applicants’ constitutional law arguments.

    From March to August 2020, the government prohibited sales of tobacco products and alcohol to help stem the spread of the coronavirus. Market leader British American Tobacco South Africa (BATSA) and smaller companies united in the Fair-Trade Independent Tobacco Association (FITA) challenged the ban, arguing that a short-term ban on a product whose health risks become evident only in the long run makes no sense.

    They also questioned the rationale of the argument around cigarette sharing. Tobacco shortages and high prices of black market cigarettes would only increase the likelihood of smokers sharing their “stompies,” the tobacco companies said.

    The government lifted the ban before the matter had been heard in court, but BATSA decided to proceed with the court action to prevent the ban from being reintroduced at a later stage of the pandemic.

    On Dec. 11, the High Court ruled that South Africa’s ban on tobacco sales during the country’s hard lockdown earlier this year was unconstitutional.

    “BATSA and our nine co-applicants had a resounding success in December with a strong judgment delivered in our favor,” said Johnny Moloto, the general manager of BATSA, in a statement. “Based on the strength of the High Court’s findings, we are confident that the Supreme Court of Appeal will uphold the Western Cape’s judgment and rule in our favor.”

    BATSA said that, instead of taking futile challenges to the Supreme Court, the government should immediately ratify the global Illicit Trade Protocol that has been sitting on its desk for close to a decade and roll out a compliant tobacco track-and-trace system.

    “Despite our confidence in the success of our case, we think the government would be wiser allocating its resources to combating the illicit trade in cigarettes, which was fortified by the ban and is now running rampant across South Africa,” said Moloto.

    In a press note, BATSA said it supports a recent call by the FITA and the South African Tobacco Organization for an investigation into the illegal trade in cigarettes.

    “This is an issue of utmost national importance that is taking huge sums out of the pockets of South Africans and putting it in to the pockets of criminals every single day. It deserves a fully resourced investigation or Commission of Inquiry with real powers,” said Moloto.

    BATSA expects the investigation to pay for itself by identifying the culprits behind the illegal trade, prosecuting them and shutting down the illegal market to return billions in lost taxes to South African citizens.

  • Smoking up During Kiwi Lockdown

    Smoking up During Kiwi Lockdown

    Photo: Tobacco Reporter archive

    Many smokers upped their cigarette consumption during New Zealand’s Covid-19 lockdown, according to new research published by the Society for Research on Nicotine and Tobacco.

    New Zealand’s response to the Covid-19 pandemic was one of the most restrictive lockdowns of any country, inevitably causing stress for many people. Because situations that increase stress and anxiety are associated with higher smoking prevalence, the researchers examined self-reported smoking before and during the lockdown, and analyzed factors associated with reported changes in cigarette consumption.

    The scientists conducted an online panel survey of a demographically representative sample of 2010 adult New Zealanders during the Covid-19 lockdown; the final, weighted sample included 261 daily smokers and 71 weekly smokers. We measured psychological distress and anxiety, as well as situational factors, tobacco consumption and demographic attributes.

    Nearly half of daily smokers reported smoking more during than before the lockdown, on average, an increase of six cigarettes a day; increased daily cigarette consumption was associated with loneliness and isolation. Most weekly smokers reported either that their smoking during the lockdown had not changed or had slightly reduced.

    “As governments introduce unprecedented measures to manage Covid-19, they need also to consider other public health risks, such as increased smoking among current smokers or relapse among recent quitters,” the authors wrote in their report. “Evidence that loneliness was associated with increased smoking during a lockdown suggests a need for cessation out-reach strategies that promote and support smoke-free practices.”

  • Heavy Smokers More Likely to be Hospitalized From Covid-19

    Heavy Smokers More Likely to be Hospitalized From Covid-19

    Photo: Taco Tuinstra

    A new study in JAMA Internal Medicine shows that heavy smokers are twice as likely as nonsmokers to be hospitalized from Covid-19. Heavy smokers are also 89 percent more likely to die from the coronavirus than nonsmokers.

    Medics from The Cleveland Clinic in Ohio and Florida analyzed more than 7,000 coronavirus patients, looking at smoking history. Those with more than 30 years of smoking history showed higher instances of hospitalization and death.

    “The findings showed a dose-response association between pack-years [number of years smoking] and adverse Covid-19 outcomes,” the medics wrote. “The results of this study suggest cumulative exposure to cigarette smoke is an independent risk factor for hospital admission and death from Covid-19.”